Literature DB >> 16248906

Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia.

Dean C Delis1, Spencer R Wetter, Mark W Jacobson, Guerry Peavy, Joanne Hamilton, Assawin Gongvatana, Joel H Kramer, Mark W Bondi, Jody Corey-Bloom, David P Salmon.   

Abstract

Memory tests that are in a recall format have almost universally measured accuracy in terms of the number of target items reported by the examinee. However, this traditional scoring method can, in certain cases, result in artificially inflated memory accuracy scores. That is, just as a "yes" response bias and high false-positive rate on recognition testing can artificially inflate a patient's hit rate, so, too, a liberal response bias and high intrusion rate on recall testing can artificially inflate a patient's level of target recall. Recognition tests correct for this problem by using a discriminability measure that provides a single score of hit rate relative to false-positive rate; however, recall tests rarely provide a single score of recall accuracy that corrects for intrusion rate. In the present study, we examined the utility of a new recall discriminability measure that analyzes target recall relative to intrusion rate. Patients with Alzheimer's disease (AD) or Huntington's disease (HD) were administered the CVLT-II, which provides both the traditional measure of target recall and a new measure of recall discriminability. The results indicate that the new recall discriminability measure was superior to the traditional level of target recall measure in distinguishing the recall performance of AD and HD patients. Implications of these results for clinical practice and theories of memory disorder in dementia are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16248906     DOI: 10.1017/S1355617705050812

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  15 in total

1.  Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  Eleni Aretouli; Jason Brandt
Journal:  Arch Clin Neuropsychol       Date:  2010-06-08       Impact factor: 2.813

Review 2.  Evolution of the diagnostic criteria for degenerative and cognitive disorders.

Authors:  Oscar L Lopez; Eric McDade; Mario Riverol; James T Becker
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

3.  Evidence for functional specialization of hippocampal subfields detected by MR subfield volumetry on high resolution images at 4 T.

Authors:  S G Mueller; L L Chao; B Berman; M W Weiner
Journal:  Neuroimage       Date:  2011-03-16       Impact factor: 6.556

4.  Verbal episodic memory profiles in HIV-Associated Neurocognitive Disorders (HAND): A comparison with Huntington's disease and mesial temporal lobe epilepsy.

Authors:  Katie L Doyle; Steven Paul Woods; Carrie R McDonald; Kelly M Leyden; Heather M Holden; Erin E Morgan; Paul E Gilbert; Jody Corey-Bloom
Journal:  Appl Neuropsychol Adult       Date:  2017-08-29       Impact factor: 2.248

5.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

6.  Construct validity of the item-specific deficit approach to the California verbal learning test (2nd Ed) in HIV infection.

Authors:  Jordan E Cattie; Steven Paul Woods; Miguel Arce; Erica Weber; Dean C Delis; Igor Grant
Journal:  Clin Neuropsychol       Date:  2012-03-07       Impact factor: 3.535

7.  Longitudinal Effects of Alcohol Consumption on the Hippocampus and Parahippocampus in College Students.

Authors:  Shashwath A Meda; Keith A Hawkins; Alecia D Dager; Howard Tennen; Sabin Khadka; Carol S Austad; Rebecca M Wood; Sarah Raskin; Carolyn R Fallahi; Godfrey D Pearlson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-03-14

8.  Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study.

Authors:  Jennifer M Coughlin; Yuchuan Wang; Cynthia A Munro; Shuangchao Ma; Chen Yue; Shaojie Chen; Raag Airan; Pearl K Kim; Ashley V Adams; Cinthya Garcia; Cecilia Higgs; Haris I Sair; Akira Sawa; Gwenn Smith; Constantine G Lyketsos; Brian Caffo; Michael Kassiou; Tomas R Guilarte; Martin G Pomper
Journal:  Neurobiol Dis       Date:  2014-11-07       Impact factor: 5.996

9.  Total recognition discriminability in Huntington's and Alzheimer's disease.

Authors:  Lisa V Graves; Heather M Holden; Lisa Delano-Wood; Mark W Bondi; Steven Paul Woods; Jody Corey-Bloom; David P Salmon; Dean C Delis; Paul E Gilbert
Journal:  J Clin Exp Neuropsychol       Date:  2016-07-21       Impact factor: 2.475

10.  Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.

Authors:  Aimee W Kao; Caroline A Racine; Lovingly C Quitania; Joel H Kramer; Chadwick W Christine; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.